To further confirm the relationship between RPN2 and MCL1, we analyzed MCL1 expression in the Cancer Genome Atlas (TCGA) database, and found that MCL1 expression was also higher in GBM primary tumors (Fig. 4d), and positively correlated with the expression of RPN2 (Fig. 4e). The gene discussed is RPN2; the disease is glioblastoma.